Back to Directory
Last Updated: 07/06/2026
ViroCell Biologics
London
Founded 2020
GMP lentiviral and retroviral vector design and manufacture for CGT
ViroCell Biologics is a specialist contract development and manufacturing organisation providing GMP design and manufacture of lentiviral and retroviral vectors for cell and gene therapy clinical trials.
The company serves academic and corporate innovators developing CAR-T therapies, rare disease gene therapies, and other advanced therapeutics requiring precisely engineered viral vectors.
Operating at clinical-grade batch sizes from 1L to 200L, ViroCell holds MHRA authorisation to manufacture and export viral vectors from its London facilities.